Vaxcyte Inc
NASDAQ:PCVX
Vaxcyte Inc
NASDAQ:PCVX
Price:
32.92
USD
-4.61%
Market Closed
Market Cap:
4.2B
USD
Income Statement
Earnings Waterfall
Vaxcyte Inc
Vaxcyte Inc
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-569.5m
USD
|
|
Operating Income
|
-569.5m
USD
|
|
Other Expenses
|
105.6m
USD
|
|
Net Income
|
-463.9m
USD
|
Income Statement
Vaxcyte Inc
Vaxcyte Inc
Currency: USD
Millions
TTM
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(49)
|
(70)
|
(90)
|
(85)
|
(88)
|
(93)
|
(104)
|
(120)
|
(144)
|
(176)
|
(209)
|
(264)
|
(304)
|
(358)
|
(393)
|
(511)
|
(577)
|
(604)
|
(570)
|
|
| Selling, General & Administrative |
(6)
|
(11)
|
(16)
|
(19)
|
(26)
|
(32)
|
(43)
|
(47)
|
(53)
|
(62)
|
(74)
|
(86)
|
(84)
|
(79)
|
(61)
|
(67)
|
(74)
|
(82)
|
(93)
|
|
| Research & Development |
(43)
|
(59)
|
(74)
|
(67)
|
(62)
|
(62)
|
(61)
|
(73)
|
(91)
|
(113)
|
(136)
|
(155)
|
(197)
|
(255)
|
(332)
|
(369)
|
(428)
|
(447)
|
(477)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(23)
|
(23)
|
(23)
|
0
|
(75)
|
(75)
|
(75)
|
0
|
|
| Operating Income |
(49)
N/A
|
(70)
-44%
|
(90)
-28%
|
(85)
+5%
|
(88)
-3%
|
(93)
-6%
|
(104)
-11%
|
(120)
-16%
|
(144)
-20%
|
(176)
-22%
|
(209)
-19%
|
(264)
-26%
|
(304)
-15%
|
(358)
-18%
|
(393)
-10%
|
(511)
-30%
|
(577)
-13%
|
(604)
-5%
|
(570)
+6%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
0
|
(1)
|
(2)
|
(0)
|
(1)
|
0
|
2
|
0
|
(1)
|
(0)
|
7
|
17
|
35
|
53
|
61
|
70
|
78
|
96
|
110
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(75)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
4
|
6
|
5
|
4
|
2
|
1
|
(4)
|
|
| Pre-Tax Income |
(47)
N/A
|
(68)
-44%
|
(89)
-30%
|
(83)
+7%
|
(87)
-4%
|
(92)
-6%
|
(100)
-8%
|
(118)
-18%
|
(143)
-21%
|
(174)
-22%
|
(223)
-28%
|
(245)
-10%
|
(265)
-8%
|
(300)
-13%
|
(402)
-34%
|
(437)
-9%
|
(497)
-14%
|
(508)
-2%
|
(464)
+9%
|
|
| Net Income | ||||||||||||||||||||
| Income from Continuing Operations |
(47)
|
(68)
|
(89)
|
(83)
|
(87)
|
(92)
|
(100)
|
(118)
|
(143)
|
(174)
|
(223)
|
(245)
|
(265)
|
(300)
|
(402)
|
(437)
|
(497)
|
(508)
|
(464)
|
|
| Net Income (Common) |
(47)
N/A
|
(68)
-44%
|
(89)
-30%
|
(83)
+7%
|
(87)
-4%
|
(92)
-6%
|
(100)
-8%
|
(118)
-18%
|
(143)
-21%
|
(174)
-22%
|
(223)
-28%
|
(245)
-10%
|
(265)
-8%
|
(300)
-13%
|
(402)
-34%
|
(437)
-9%
|
(497)
-14%
|
(508)
-2%
|
(464)
+9%
|
|
| EPS (Diluted) |
-0.93
N/A
|
-1.34
-44%
|
-3.02
-125%
|
-1.63
+46%
|
-1.69
-4%
|
-1.76
-4%
|
-1.93
-10%
|
-2.04
-6%
|
-2.34
-15%
|
-2.8
-20%
|
-3.44
-23%
|
-2.84
+17%
|
-2.7
+5%
|
-2.94
-9%
|
-4.14
-41%
|
-3.91
+6%
|
-4.24
-8%
|
-4.1
+3%
|
-3.8
+7%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
